Editorial Commentary: Stemming the Tide: Can New Approaches to HIV Treatment Reverse the Trend of Rising Drug Prices in the United States?

Clin Infect Dis. 2016 Mar 15;62(6):792-4. doi: 10.1093/cid/civ986. Epub 2015 Dec 9.

Authors

Serena P Koenig¹, Jean W Pape²

Affiliations

¹ Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts.
² Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections, Port-au-Prince, Haiti Center for Global Health, Weill Cornell Medical College, New York, New York.

PMID: 26658055
DOI: 10.1093/cid/civ986

No abstract available

Keywords: HIV; antiretroviral therapy; cost; cost-effectiveness.

Publication types

Editorial
Comment

MeSH terms

Anti-HIV Agents / therapeutic use*
Antiretroviral Therapy, Highly Active*
Cost-Benefit Analysis
HIV Infections / drug therapy
Humans
United States

Substances

Anti-HIV Agents